In vitro antimicrobial activity of ritipenem acoxil and its therapeutic efficacy in respiratory tract infections

Pharmacology, Toxicology and Pharmaceutical Science

• Ritipenem Acoxil 100%
• Staphylococcus Aureus 50%
• Infection 40%
• Respiratory Tract Infection 30%
• Pseudomonas aeruginosa 30%
• Haemophilus influenzae 30%
• Minimum Inhibitory Concentration 30%
• Adverse Event 20%
• Antiinfective Agent 20%
• Aspartate Aminotransferase 20%
• Escherichia coli 20%
• Lung Tuberculosis 20%
• Cefaclor 20%
• Cefteram 20%
• Klebsiella pneumoniae 10%
• Drug Eruption 10%
• Alanine Aminotransferase 10%
• Pneumonia 10%
• Streptococcus Pneumoniae 10%
• Moraxella catarrhalis 10%
• Antibiotic Agent 10%
• Serratia marcescens 10%
• Organisms 10%
• Enterobacter Cloacae 10%
• Bronchiectasis 10%
• Lung Fibrosis 10%
• Chronic Bronchitis 10%
• Anorexia 10%
• Lobar Pneumonia 10%
• Lung Emphysema 10%
• Bronchitis 10%
• Shewanella putrefaciens 10%
• Bronchopneumonia 10%
• Clinical Trial 10%
• Antibiotics 10%